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of Consequence
See also Galea and Vaughan, p. 973.
understand the potential impact
of a specific public health policy
in a real population, establishing
internal validity is merely a first
step; we must also consider ex-
ternal validity and population
intervention impact, which to-




Here we focus on generating
evidence for public health action
beginning with an individually
randomized trial (or observa-
tional study conducted in place
of a trial). In particular, consider
a randomized trial of antiretroviral
agents for preexposure pro-
phylaxis for HIV prevention
(PrEP), in which an active arm
is compared with a placebo in
a group of HIV-negative volun-
teers who are followed up
through regular clinic visits to
identify new HIV infections.
With perfect follow-up, a com-
parison of unadjusted survival
curves between the active and
placebo trial arms will yield a valid
estimate of the causal effect of
assignment toPrEPon riskofHIV
acquisition in the study sample.2
The difference in outcomes
between participants assigned to
each treatment arm, allowing for
differential adherence, is typically
referred to as the effectiveness of
the treatment. We often prioritize
effectiveness of an intervention
strategy over its efficacy (effect
under perfect adherence or in
laboratory settings) because in
the real world we cannot force
people to adhere to an in-
tervention. Accordingly, effec-
tiveness is sometimes referred to
as the public health effect of the
treatment. However, further
work is needed to translate ef-
fectiveness to an estimate of the
impact of an intervention in a real
population.
EXTERNAL VALIDITY
An essential ingredient of the
causal impact framework is the
ability to generalize or transport
to populations beyond that under
study; thus, we must consider
possible differences in character-
istics between our study sample
and our target population, the
population in which we want to
implement the intervention.3 If
the study sample is a random
sample of the target population,
external validity is guaranteed in
expectation. However, study
samples and target populations
nearly always differ systematically
because of factors such as in-
clusion and exclusion criteria in
a trial and self-selection into
studies through the informed
consent process. These differ-
ences may modify the impact of
the intervention in the target
population, leading to external
validity bias. In the trial just de-
scribed, if PrEP is more effective
at preventing HIV in women
than in men, and if women were
more likely to participate in
the trial than men, then PrEP
could appear more effective in
the trial than it would be in the
target population.
In such a simple case, the ef-
fectiveness of PrEP in the target
population can be estimated by
standardization. But if the effec-
tiveness of the intervention
varied because of a complex
combination of several variables
(e.g., gender, age, race) the joint
distribution of which differed
between the study sample and
the target population, then
model-based strategies are
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The causal impact framework 
is a conceptual framework 
encompassing internal validity, 
external validity, and population 
intervention effects, which we 
argue can help us produce evi-
dence of greater utility to public 
health decision-making.
To improve the health of
a population, public health re-
search should consider factors 
that can be changed, particularly 
exposures that are potential tar-
gets of intervention. Thus, useful 
public health research will focus 
on identifying causes of health 
and disease, rather than simply 
associated risk factors. Such causal 
public health (and clinical) re-
search designs generally focus on 
ensuring internal validity1: gen-
erating an accurate estimate of 
a causal effect for the people in 
the study, such as obtained from 
a double-masked randomized 
controlled trial with no loss to 
follow-up. In such a trial setting, 
we are typically interested in 
contrasting two exposure distri-
butions: (1) what if everyone 
were assigned to the experi-
mental treatment, and (2) what if 
everyone were assigned to the 
comparison treatment?
This focus on internal validity 
informs the conduct and 
reporting of randomized trials 
and the framing of observational 
data analysis. Yet, if our goal is to
not likely captured in a small
study sample. Finally, imple-
mentation challenges may lead to
adaptation of the intervention
when scaling up from a study to
a population.
Nonexperimental settings
raise additional challenges: ob-
servational public health research
often focuses on effects of
harmful exposures, rather than on
interventions to limit such ex-
posures. Using the results of
a study of the effect of a harmful
exposure (e.g., smoking) to
estimate the potential effect of
a population intervention to
reduce prevalence of that expo-
sure (e.g., mass campaign for
smoking prevention) requires
articulation of assumptions about
the intervention in question
and its side effects,5,6 and careful
estimation (possibly using the
g-methods of Robins, as in
Westreich6). Population inter-
vention effects,5,7 which can be
thought of informally as causal
effects tied to contrasts between
the observed population and
exposure distributions under re-
alistic interventions, are of key
importance to the causal impact
framework goal of translating
scientific results into policy-
relevant findings. Such effects
may serve as more natural inputs
into cost-effectiveness and
decision-theoretic models than
typically reported study results.
REMARKS
There are numerous ap-
proaches for the estimation
of policy-relevant public health
effects, including large-scale
representative and pragmatic
randomized trials and compara-
tive interrupted time series.1
Despite calls for wider adoption
of these methods,1 traditional
randomized trials and non-
experimental studies remain
central to the production of ev-
idence for public health practice. 
Such studies are valuable, but 
typically focus centrally on 
questions of internal validity, 
ignoring external validity and 
population intervention impact. 
Considering all three, as in the 
causal impact framework, may 
help us produce research more 
relevant to policymaking and, 
thus, help produce a Public 
Health of Consequence.
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recommended.3 Of course, if one 
or more of those variables were 
unmeasured, no quantitative 
approach would be guaranteed 
to provide an accurate estimate of 
the true population effect (a close 
parallel to the problem of un-
controlled confounding in an 
observational study). There is
a growing literature on quanti-
tative methods to “generalize” 
results from a study sample to 
the population from which the 
sample was selected,3 and to
“transport” results from a study 
sample to a different population 
entirely.4 However, even if we 
successfully estimate the effec-
tiveness of a proposed in-
tervention in a target population, 
in the causal impact framework 
we must make efforts to un-
derstand the effect of the in-





As noted earlier, in our trial 
setting, we are likely contrasting 
two exposure distributions: (1) 
what if everyone were assigned 
to PrEP, and (2) what if everyone 
were assigned to placebo?
But the real-world effects of
a population-level PrEP inter-
vention (e.g., a countrywide 
policy to promote PrEP to all 
people who meet certain criteria) 
may well differ from what is es-
timated in a specific trial. On one 
hand, not everyone will be tar-
geted by PrEP campaigns, nor 
will everyone targeted choose 
to take the treatment, and ad-
herence may be better in a trial 
because of Hawthorne effects. 
On the other hand, preventing 
a single HIV infection with PrEP 
may prevent subsequent trans-
mission events, a dependency
